The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Sites of Tau Important for Aggregation Populate β-Structure and Bind to Microtubules and Polyanions
Open accessAbstract
The aggregation of the microtubule-associated tau protein and formation of “neurofibrillary tangles” is one of the hallmarks of Alzheimer disease. The mechanisms underlying the structural transition of innocuous, natively unfolded tau to neurotoxic forms and the detailed mechanisms of binding to microtubules are largely unknown. Here we report the high-resolution characterization of the repeat domain of soluble tau using multidimensional NMR spectroscopy. NMR secondary chemical shifts detect residual β-structure for 8–10 residues at the beginning of repeats R2–R4. These regions correspond to sequence motifs known to form the core of the cross-β-structure of tau-paired helical filaments. Chemical shift perturbation studies show that polyanions, which promote paired helical filament aggregation, as well as microtubules interact with tau through positive charges near the ends of the repeats and through the β-forming motifs at the beginning of repeats 2 and 3. The high degree of similarity between the binding of polyanions and microtubules supports the hypothesis that stable microtubules prevent paired helical filament formation by blocking the tau-polyanion interaction sites, which are crucial for paired helical filament formation. The aggregation of the microtubule-associated tau protein and formation of “neurofibrillary tangles” is one of the hallmarks of Alzheimer disease. The mechanisms underlying the structural transition of innocuous, natively unfolded tau to neurotoxic forms and the detailed mechanisms of binding to microtubules are largely unknown. Here we report the high-resolution characterization of the repeat domain of soluble tau using multidimensional NMR spectroscopy. NMR secondary chemical shifts detect residual β-structure for 8–10 residues at the beginning of repeats R2–R4. These regions correspond to sequence motifs known to form the core of the cross-β-structure of tau-paired helical filaments. Chemical shift perturbation studies show that polyanions, which promote paired helical filament aggregation, as well as microtubules interact with tau through positive charges near the ends of the repeats and through the β-forming motifs at the beginning of repeats 2 and 3. The high degree of similarity between the binding of polyanions and microtubules supports the hypothesis that stable microtubules prevent paired helical filament formation by blocking the tau-polyanion interaction sites, which are crucial for paired helical filament formation. Alzheimer disease is characterized by abnormal protein deposits in the brain, such as amyloid plaques or neurofibrillary tangles, formed by fibrous assemblies of the Aβ peptide (1Selkoe D.J. Schenk D. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 545-584Crossref PubMed Scopus (754) Google Scholar) or of the microtubule (MT) 1The abbreviations used are: MT, microtubule; PHF, paired helical filament; MES, 4-morpholineethanesulfonic acid; Pipes, 1,4-piperazinediethanesulfonic acid; HSQC, heteronuclear single quantum correlation. -associated tau protein (2Mandelkow E.M. Mandelkow E. Trends Cell Biol. 1998; 8: 425-427Abstract Full Text Full Text PDF PubMed Scopus (445) Google Scholar). These aggregates are thought to be toxic to neurons, either by causing some toxic signaling defect or by obstructing the cell interior. Therefore, one of the top priorities in Alzheimer research is to understand the reasons for the pathological aggregation and to find methods to prevent it. Although the structural principles governing Aβ aggregation are known in some detail, little is known for the tau protein. Tau is a microtubule-associated protein that regulates MT stability, neurite outgrowth, and other MT-dependent functions. The three or four repeats in the C-terminal half of the protein and the flanking proline-rich basic domains are known to be involved in MT binding (3Gustke N. Trinczek B. Biernat J. Mandelkow E.M. Mandelkow E. Biochemistry. 1994; 33: 9511-9522Crossref PubMed Scopus (547) Google Scholar). The affinity is regulated by phosphorylation particularly at KXGS-motifs in the repeats (4Biernat J. Gustke N. Drewes G. Mandelkow E.M. Mandelkow E. Neuron. 1993; 11: 153-163Abstract Full Text PDF PubMed Scopus (662) Google Scholar). Interestingly the same phosphorylation sites have an inhibitory influence on aggregation (5Schneider A. Biernat J. von Bergen M. Mandelkow E. Mandelkow E.M. Biochemistry. 1999; 38: 3549-3558Crossref PubMed Scopus (460) Google Scholar). Unbound tau can assemble into Alzheimer-like paired helical filaments (PHFs) whose polymerization can be enhanced by oxidation of SH groups and by polyanions (e.g. heparin, poly-Glu (6Barghorn S. Mandelkow E. Biochemistry. 2002; 41: 14885-14896Crossref PubMed Scopus (286) Google Scholar)). On the other hand, tau has a hydrophilic character, is highly soluble, and belongs to the class of natively unfolded proteins with no apparent ordered secondary structure detectable by far-UV CD or Fourier-transform infrared spect
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hexapeptide VQIINK motifs in the second repeat and VQIVYK in the third repeat within the tau microtubule-binding domain are crucial for the formation of β-sheet structures and consequent tau aggregation [221, 222].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [221]
In the citing paper
“These good correlations between the REMD- and NMR-derived Cα chemical shifts indicate that the REMD-generated conformational ensemble of K18 monomer is consistent with previous NMR data.371”
From Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell (2016) · cites this paper as [371]
In the citing paper
“The REMD-predicted and experimentally measured Cα SCSs show a Pearson correlation coefficient of 0.614 (Fig. 6 C), consistent with previous NMR data.371”
From Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell (2016) · cites this paper as [371]
In the citing paper
“Protein-protein interfaces are characterized by the existence of hot spots or ‘hot regions’ in interacting regions instead of an even contribution across all contact areas.371,476,487,492–495”
From Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell (2016) · cites this paper as [371]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961
Why are ?natively unfolded? proteins unstructured under physiologic conditions?
Uversky, V. N., Gillespie, J. R., & Fink, A. L. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(20001115)41:3 · Cited by 2,097
Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A. (1996) · Nature · doi:10.1038/383550a0 · Cited by 1,036
Mandelkow, E. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01368-3 · Cited by 980
Self-citationWischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
[12] Chemical shifts as a tool for structure determination
Wishart, D. S., & Sykes, B. D. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)39014-2 · Cited by 874
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 829
Bertoncini, C. W., Jung, Y., Fernández, C. O., Hoyer, W., Griesinger, C., Jovin, T. M., & Zweckstetter, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407146102 · Cited by 802
Self-citationBiernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796
Self-citationMethodological advances in protein NMR
Bax, A., & Grzesiek, S. (1993) · Accounts of Chemical Research · doi:10.1021/ar00028a001 · Cited by 775
Flagged first, then by citations
Research works printed but not linked: 2
- von Bergen, 2000, Mol. Biol. Cell, 11, 363A
- Craik, 1997, Methods Mol. Biol., 60, 195
Cited by
Sorted by citations
Items 201–300 of 325
Zhu, L., Gong, Y., Lju, H., Sun, G., Zhang, Q., & Qian, Z. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp03142b · Cited by 23
Heparan Sulfate Proteoglycans in Tauopathy
Zhu, Y., Gandy, L. A., Zhang, F., Liu, J., Wang, C., Blair, L. J., Linhardt, R. J., & Wang, L. (2022) · Biomolecules · doi:10.3390/biom12121792 · Cited by 27
Jansen, S., Melková, K., Trošanová, Z., Hanáková, K., Zachrdla, M., Nováček, J., Župa, E., Zdráhal, Z., Hritz, J., & Žı́dek, L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771097 · Cited by 21
Melková, K., Zapletal, V., Jansen, S., Nomilner, E., Zachrdla, M., Hritz, J., Nováček, J., Zweckstetter, M., Jensen, M. R., Blackledge, M. J., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001769 · Cited by 23
Self-citationInsights into the Structural Conformations of the Tau Protein in Different Aggregation Status
Pinzi, L., Bisi, N., Sorbi, C., Franchini, S., Tonali, N., & Rastelli, G. (2023) · Molecules · doi:10.3390/molecules28114544 · Cited by 20
14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells
Li, T., & Paudel, H. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160635 · Cited by 21
Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation
Annadurai, N., Malina, L., Malohlava, J., Hajdúch, M., & Das, V. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.013 · Cited by 18
Fucoidans inhibited tau interaction and cellular uptake
Jin, W., Lu, C., Zhu, Y., Zhao, J., Zhang, W., Wang, L., Linhardt, R. J., Wang, C., & Zhang, F. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120176 · Cited by 19
Yang, D., Shi, S., Zheng, L., Yao, T., & Ji, L. (2010) · Biopolymers · doi:10.1002/bip.21527 · Cited by 20
Key Physicochemical and Biological Factors of the Phase Behavior of Tau
Nam, G., Lin, Y., Lim, M. H., & Lee, Y. (2020) · Chem · doi:10.1016/j.chempr.2020.09.012 · Cited by 20
Exploring the role of mitochondrial proteins as molecular target in Alzheimer’s disease
Chadha, S., Behl, T., Sehgal, A., Kumar, A., & BUNGAU, S. G. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.11.008 · Cited by 20
Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members
Hwang, A. W., Trzeciakiewicz, H., Friedmann, D., Yuan, C., Marmorstein, R., Lee, V. M. ‐., & Cohen, T. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168913 · Cited by 18
NMR studies of amyloid interactions
Middleton, D. A. (2024) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2024.07.001 · Cited by 21
NMR Studies of Tau Protein in Tauopathies
Kitoka, K., Škrabana, R., Gašparik, N., Hritz, J., & Jaudzems, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.761227 · Cited by 17
Induced folding in RNA recognition byArabidopsis thalianaDCL1
Suárez, I. P., Burdisso, P., Benoit, M. P. M. H., Boisbouvier, J., & Rasia, R. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv627 · Cited by 17
InP Quantum Dots: Probing the Active Domain of Tau Peptide Using Energy Transfer
Thirunavukkuarasu, S., George, A., Thomas, A. A., Thomas, A., Vijayan, V., & Thomas, K. G. (2018) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.8b01533 · Cited by 17
Alarcón‐Espósito, J., Mallea, M., & Rodríguez-Lavado, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200914155951 · Cited by 19
Interaction of Tau construct K18 with model lipid membranes
Azouz, M., Feuillie, C., Lafleur, M., Molinari, M., & Lecomte, S. (2021) · Nanoscale Advances · doi:10.1039/d1na00055a · Cited by 16
Hairpin trimer transition state of amyloid fibril
Sari, L., Bali, S., Joachimiak, Ł. A., & Lin, M. M. (2024) · Nature Communications · doi:10.1038/s41467-024-46446-x · Cited by 18
Poly(4-styrenesulfonate) as an Inhibitor of Aβ40 Amyloid Fibril Formation
Ojha, B., Liu, H., Dutta, S., Rao, P. P. N., Wojcikiewicz, E. P., & Du, D. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4065467 · Cited by 17
Cecon, E., Oishi, A., Luka, M., Ndiaye‐Lobry, D., François, A., Lescuyer, M., Panayi, F., Dam, J., Machado, P., & Jockers, R. (2023) · eLife · doi:10.7554/elife.78360 · Cited by 17
Chatterjee, S., Salimi, A., & Lee, J. Y. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp00105a · Cited by 15
Nieznańska, H., Boyko, S., Dec, R., Rędowicz, M. J., Dzwolak, W., & Nieznański, K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166209 · Cited by 16
α-Synuclein and tau, two targets for dementia
Silva, M., Caro, V., Guzmán, C., Perry, G. L., Areche, C., & Cornejo, A. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00001-1 · Cited by 15
Therapeutic strategies for tauopathies and drug repurposing as a potential approach
Islam, M., Shen, F., Regmi, D., & Du, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114979 · Cited by 14
Jangholi, A., Ashrafi-Kooshk, M. R., Arab, S. S., Karima, S., Poorebrahim, M., Ghadami, S. A., Moosavi‐Movahedi, A. A., & Khodarahmi, R. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.071 · Cited by 13
Nadimidla, K., Ismail, T., & Kanapathipillai, M. (2017) · Biopolymers · doi:10.1002/bip.23024 · Cited by 13
Ahmad, W., Shabbiri, K., & Ahmad, I. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.176 · Cited by 12
Target-binding behavior of IDPs via pre-structured motifs
Kim, D.-H., & Han, K. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.07.031 · Cited by 12
Effects of Charged Polyelectrolytes on Amyloid Fibril Formation of a Tau Fragment
Islam, M., Argueta, E., Wojcikiewicz, E. P., & Du, D. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00374 · Cited by 12
Zou, Y. F., Guan, L., Tan, J., Qi, B., Wang, Y., Zhang, Q., & Sun, Y. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c07568 · Cited by 12
Therapeutic Targets in Alzheimer's Disease and Related Tauopathies
Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13
Structural Insights into Intrinsically Disordered Proteins by Small‐Angle X‐Ray Scattering
Bernadó, P., & Svergun, D. I. (2010) · doi:10.1002/9780470602614.ch16 · Cited by 12
RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
Medd, M. M., Yon, J. E., & Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020124 · Cited by 11
Sahayaraj, A. E., Viswanathan, R., Pinhero, F., Vahid, A. A., & Vijayan, V. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00602 · Cited by 11
Chen, Y., Sun, X., Tang, Y., Tan, Y., Guo, C., Pan, T., Zhang, X., Luo, J., & Wei, G. (2024) · Small · doi:10.1002/smll.202406429 · Cited by 10
Sun, K. T., & Mok, S. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00512 · Cited by 12
Zhu, S., Song, Z., Tapayan, A. S., Singh, K., Wang, K., Hagar, H. C., Zhang, J., Kim, H., Thepsuwan, P., Kuo, M., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02563 · Cited by 10
An amphiphilic material arginine–arginine–bile acid promotes α-synuclein amyloid formation
Lin, Y., Park, S.-H., Bok, E., Heo, Y., Yang, S.-B., Yi, Y.-S., Lee, J.-H., Seo, D., Jo, E., Lim, S., et al. (2023) · Nanoscale · doi:10.1039/d3nr01468a · Cited by 9
Conformational signatures induced by ubiquitin modification in the amyloid-forming tau repeat domain
Viola, G., Trivellato, D., Laitaoja, M., Jänis, J., Felli, I. C., D’Onofrio, M., Mollica, L., Giachin, G., & Assfalg, M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2425831122 · Cited by 9
Direct Observation of the Self‐Aggregation of R3R4 Bi‐repeat of Tau Protein
Jayan, P., Vahid, A. A., Kizhakkeduth, S. T., Muhammed, S. O. H., Shibina, A. B., & Vijayan, V. (2021) · ChemBioChem · doi:10.1002/cbic.202100013 · Cited by 8
Verelst, J., Geukens, N., Eddarkaoui, S., Vliegen, D., Smidt, E. D., Rosseels, J., Franssens, V., Molenberghs, S., François, C., Stoops, E., et al. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00048 · Cited by 11
Pharmacophore-based Drug Design of Novel Potential Tau Ligands for Alzheimer's Disease Treatment
Mantoani, S. P., da Silva, V. S., Taft, C. A., & da Silva, C. H. T. D. P. (2014) · Current Physical Chemistry · doi:10.2174/18779468113036660020 · Cited by 8
Dan, A., & Chen, H. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13407 · Cited by 8
Tau Fibrillation Induced by Heparin or a Lysophospholipid Show Different Initial Oligomer Formation
Rasmussen, H. Ø., Nielsen, J., de Poli, A., Otzen, D. E., & Pedersen, J. S. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168194 · Cited by 7
Diamond, M. I. (2023) · Cytoskeleton · doi:10.1002/cm.21806 · Cited by 5
Untangling the Complexity and Impact of Tau Protein Ubiquitination
Trivellato, D., Munari, F., Assfalg, M., Capaldi, S., & D’Onofrio, M. (2024) · ChemBioChem · doi:10.1002/cbic.202400566 · Cited by 6
Marreiro, A. F. D., Kolen, K. V., Sousa, C., Temmerman, L., Vasconcelos, B., Rodriguez, R. C., van Weering, J. R. T., Dam, D. V., Deyn, P. P. D., Apetri, A. C., et al. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00320-y · Cited by 6
Mechanismus der Phenothiazin‐induzierten Hemmung der Tau‐Aggregation
Akoury, E., Pickhardt, M., Gajda, M. J., Biernat, J., Mandelkow�, E., & Zweckstetter, M. (2013) · Angewandte Chemie · doi:10.1002/ange.201208290 · Cited by 6
Self-citationEffect of cellular polyanion mimetics on tau peptide aggregation
Ismail, T., & Kanapathipillai, M. (2018) · Journal of Peptide Science · doi:10.1002/psc.3125 · Cited by 6
Understanding molecular features of aggregation-resistant tau conformer using oxidized monomer
Jebarupa, B., Mathew, B., Srinivasu, B. Y., Sasikumaran, A., Joseph, S., Mandal, A. K., Thomas, T. S., & Mitra, G. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.03.006 · Cited by 6
Atsmon‐Raz, Y., & Miller, Y. (2015) · Israel Journal of Chemistry · doi:10.1002/ijch.201400162 · Cited by 6
Model-Dependent Solvation of the K-18 Domain of the Intrinsically Disordered Protein Tau
Maiti, S., & Heyden, M. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01726 · Cited by 5
Optical signature of retinal Tau fibrillation
Salajková, Z., Barolo, L., Baiocco, P., Ruzicka, B., Mura, F., Lorenzo, F. D., Boffi, A., Ricco, V., Ruocco, G., & Leonetti, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-92565-w · Cited by 5
Stress granule‐mediated RNA regulatory mechanism in Alzheimer's disease
Sato, K., Takayama, K., & Inoue, S. (2023) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14663 · Cited by 5
Pellkofer, H., Ihler, F., Weiss, B. G., Trothe, J., Kadavath, H., Chongtham, M. C., Kunadt, M., Riedel, D., Lornsen, F., Wilken, P., et al. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0955-6 · Cited by 5
Self-citationIslam, M., Karim, M. R. U., Argueta, E., Selim, M. N., Wojcikiewicz, E. P., & Du, D. (2025) · Membranes · doi:10.3390/membranes15070208 · Cited by 4
Targeted tau protein degradation: a promising therapeutic approach for tauopathies
Baazaoui, N., Alfaifi, M. Y., Shati, A. A., Saad, R. B., & Garzoli, S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.041 · Cited by 5
Molecular-level interplay between intrinsically disordered clients and Hsp90
Ramirez, L. M., & Zweckstetter, M. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102304 · Cited by 4
Self-citationParimalam, S. S., Tarhan, M. C., Karsten, S. L., Fujita, H., Shintaku, H., Kotera, H., & Yokokawa, R. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.07.082 · Cited by 4
Chaudhary, N., & Nagaraj, R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_4 · Cited by 4
Shapeshifting tau: from intrinsically disordered to paired-helical filaments
Mengham, K., Al‐Hilaly, Y. K., Oakley, S. S., Kasbi, K., Maina, M. B., & Serpell, L. C. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220150 · Cited by 4
Kizhakkeduth, S. T., Vahid, A. A., Hassan, M. S. O., Parambil, A. K., Jain, P., & Vijayan, V. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00456 · Cited by 3
Bhandari, A. K., Dhami, A. S., Hemanthlumar, R. T., Mishra, N., Joslyn, B., Roy, S., Srinivasan, J., Prajapati, K. P., Kar, K., & Anand, B. G. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102879 · Cited by 4
Montgomery, K. M., Samelson, A. J., & Gestwicki, J. E. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202300104 · Cited by 4
Jankovičová, B., Svobodová, Z., Hromádková, L., Kupčík, R., Řı́pová, D., & Bı́lková, Z. (2015) · Universal Journal of Biomedical Engineering · doi:10.13189/ujbe.2015.030101 · Cited by 3
Honisch, C., Torni, F., Hussain, R., Ruzza, P., & Siligardi, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062932 · Cited by 3
Mandelkow, E., Thies, E., & MANDELKOW, E. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_14 · Cited by 4
Self-citationStructural and mechanistic characterization of heparin interactions with tau fibrils
Mon, F., & Straub, J. E. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111153 · Cited by 2
Saha, D., Sun, X., Yang, W., Luo, J., & Zheng, W. (2026) · JACS Au · doi:10.1021/jacsau.6c00126 · Cited by 2
Image-Based Analysis of Intracellular Tau Aggregation by Using Tau-BiFC Cell Model
Lim, S., Kim, D., Kim, D. J., & Kim, Y. K. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_22 · Cited by 2
Neuroprotective effects of oleocanthal in neurological disorders
Batarseh, Y. S., Rihani, S. B. A., Yang, E., & Kaddoumi, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819528-4.00055-9 · Cited by 2
Chatterjee, P., Cho, M. K., Bui, H. T., & Ham, S. (2021) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12334 · Cited by 2
Chatterjee, P., Le, T., Bui, H. T., Cho, M. K., & Ham, S. (2021) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12338 · Cited by 2
Tau local structure shields amyloid motif and controls aggregation propensityPreprint
Chen, D., Drombosky, K. W., Hou, Z., Sari, L., Kashmer, O. M., Ryder, B. D., Perez, V. A., Woodard, D. R., Lin, M. M., Diamond, M. I., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/330266 · Cited by 3
Lee, J., Lee, K., Kim, M. S., Kim, M. W., Lim, M., Yoo, J., & Lee, S. H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563032 · Cited by 2
Tau Protein: Targets And Development Against Alzheimer’s Disease
Dubey, S., & Mahesh, A. R. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010010 · Cited by 1
Arar, S. H., Haque, M. A., Kayed, A., Khan, S., Bhatt, N. N., Zhao, Y., & Kayed, R. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00122 · Cited by 1
Tau Folding and Assembly Triggered by Electroreduction of Its Protonated Amino Acids
Masquelier, E., Fojut, S., Faraji, X., Tochikura, S. K., Yi, J., Sepunaru, L., Gordon, M. J., & Morse, D. E. (2025) · ACS electrochemistry. · doi:10.1021/acselectrochem.5c00213 · Cited by 1
Polyamine and tau: a chemical framework for understanding the hyperphosphorylated tau condensation
Lee, J., Lee, K. ‐., Kim, M., Kim, M. K., Lim, M., Yoo, J., & Lee, S. H. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152366 · Cited by 1
Tau and Intracellular Transport in Neurons
Mandelkow, E., Thies, E., Konzack, S., & Mandelkow, E. (2009) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-87941-1_5 · Cited by 1
Self-citationMalyshka, D., Jimenez-Harrison, D., & Kuret, J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3629-9_7 · Cited by 1
Sahayaraj, A. E., Vahid, A. A., Dhara, A., Babu, A. T., & Vijayan, V. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c00123 · Cited by 1
Experimental Models of Tau Aggregation
Buck, K., Jahn, T. R., & Gasparini, L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00070-1 · Cited by 1
Azouz, M. (2019) · theses.fr (ABES) · doi:10.70675/4c3b6c12z1da5z497cz9e34zea6e6bf189d9 · Cited by 1
Biernat, J., Khlistunova, I., Wang, Y.-P., Pickhardt, M., von Bergen�, M., Gažová, Z., Mandelkow, E., & Mandelkow, E. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_34
Self-citationThe Structural Biology of IDPs inside Cells
Selenko, P. (2010) · Wiley eBooks · doi:10.1002/9780470602614.ch2
Conformation of Human Microtubule Associated Protein-Tau
Jeganathan�, S. (2008) · Max Planck Institute for Plasma Physics
Chapter 4 Tau Protein and the Dementias
Goedert, M., & Spillantini, M. G. (2007) · Blue books of neurology · doi:10.1016/s1877-184x(09)70055-3
Intrinsically Disordered Proteins
Rezaei‐Ghaleh, N., & Zweckstetter, M. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0023212
Self-citationConformational And Assembly Studies Of Two Tau Repeats: 2R and 3R
Koshiari, C. P. (2006) · University Libraries (University of Maryland)
Structural Basis for Ternary Complex Formation between Tau, Hsp90, and FKBP51
Barrett, A. S., Wu, H., Kashtanov, S., & Daughdrill, G. W. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.11.2162
Molecular Mechanisms of Tau Protein Aggregation Inhibition
Akoury, E. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4145
Seeded propagation of Tau fibrils
Dinkel, P. D. (2013) · Digital Commons - DU (University of Denver)
The Cytoskeleton as a Pharmacological Target in Neurodegenerative Diseases
Oz, S., & Gozes, I. (2012) · Neuromethods · doi:10.1007/978-1-62703-266-7_8
The endolysosomal system in neuronal physiology and pathology
Sanchez, S. V. (2019)
Harilal, C. C. (2019) · DUT Open Scholar (Durban University of Technology) · doi:10.51415/10321/3608
(2009) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420078930.bmatt
A metabolite extracted from Escherichia coli suppresses tau aggregation
Srinivasan, M., Patel, A., Patel, T., Moore, J., Gomez‐Cardona, E., Yarahmady, A., Sykes, B. D., Julien, O., & Mok, S. (2026) · Biochemical Journal · doi:10.1042/bcj20260068
N -Linked Glycosylation as a Driver of Tau Pathology and Neuronal TransmissionPreprint
Basta, T., Herlory, M., Holland, P., Stojkovic, R., Powell, W. C., & Walczak, M. A. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.01.690311
Metadata
- Authors
- Mukrasch, M. D., Biernat, J., von Bergen, M., Griesinger, C., Mandelkow, E., & Zweckstetter, M.
- Affiliations
- Max Planck Institute for Biophysical Chemistry (DE)
- Deutsches Elektronen-Synchrotron DESY (DE)
- Corresponding author
- Zweckstetter, Markus
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 280
- Issue
- 26
- Pages
- 24978-24986
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2079615523
- Cited by
- 324
- References
- 39
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 10 · 2023: 18 · 2022: 20 · 2021: 21 · 2020: 23 · 2019: 24 · 2018: 21 · 2017: 11 · 2016: 17 · 2015: 13 · 2014: 13 · 2013: 16 · 2012: 17
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- GRO (submittedVersion)
- Funders
- European Commission
- Deutsche Forschungsgemeinschaft
- Max-Planck-Gesellschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau protein, protein aggregation, neurofibrillary tangles, Alzheimer's disease, microtubule binding, polyanion binding, paired helical filaments, cross-β structure, tau repeat domain, secondary structure, chemical shift perturbation, protein-protein interaction sites, intrinsically disordered proteins, microtubule stabilization, chemical shift assignment
- MeSH terms
- Polyelectrolytes, Alzheimer Disease, Amino Acid Sequence, Animals, Anions, Brain, Electrophoresis, Polyacrylamide Gel, Humans, Lysine, Microtubules, Molecular Sequence Data, Mutation, Magnetic Resonance Spectroscopy, Polymers, Protein Binding, Swine, Temperature, Tubulin, Neurofibrillary Tangles, tau Proteins, Sequence Homology, Amino Acid, Protein Structure, Secondary, Protein Structure, Tertiary, Protein Folding, Crystallography, X-Ray, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
